contectless medical treatment

Culture & Trends S.Korea’s medical tourism thrives on weak currency

Foreign visitors to South Korea jumped nearly 20% early this year, largely driven by a sharp depreciation in the country’s currency value agai...

Mergers & Acquisitions LG Chem’s medical skincare business sale draws tepid bid

South Korean chemical giant LG Chem Ltd.'s offer for sale of its cosmetics filler business, tagged with an asking price of more than 500 billion won...

Bio & Pharma Celltrion wins EU approval for autoimmune disease treatment Avtozma

Celltrion Inc.’s Avtozma, a biosimilar to Roche’s autoimmune disease treatment Actemra, has won approval from the European Commission, f...

Corporate restructuring SK Ecoplant seeks to sell waste treatment business for $1.4 billion

SK Ecoplant Co., a South Korean construction engineering and waste management company under SK Group, is seeking to dispose of its waste treatment b...

Medical devices Middle East: New land of opportunity for Korean medical devices

South Korea is making inroads into the Middle East's medical device market dominated by the US and Europe, aiming to leverage the region’s str...

Mergers & Acquisitions LG Chem embarks on sale of dermal filler business worth $343 million

LG Chem Ltd., the world’s fourth-largest chemicals producer that is fostering vaccine and new drug development as new growth drivers, has kick...

Bio & Pharma Celltrion’s Vegzelma: Most-prescribed cancer treatment in Europe

South Korea’s leading biosimilar drug developer Celltrion Inc.'s Vegzelma, a cancer drug referencing global biopharma Roche’s Avastin, h...

Bio & Pharma Partners Investment, GordonMD eye $150 mn biotech fund launch

South Korean venture capital firm Partners Investment said on Thursday it will raise up to 215.5 billion won ($150 million) in a biotech fund jointl...

Robotics Koh Young gets OK from FDA for brain surgery robot

Koh Young Technology Inc., a South Korean developer of 3D optical inspection devices used in electronics manufacturing, said on Monday it got 501K...

Bio & Pharma Yuhan’s lung cancer drug gets OK in Europe

Leclaza (ingredient: lazertinib), a new lung cancer treatment developed by South Korea’s Yuhan Corp. secured approval from the European Commis...

Bio & Pharma Celltrion obtains approval of Steqeyma from FDA

South Korea's Celltrion Inc. said on Wednesday it received new drug submission (NDS) approval from the Food and Drug Administration (FDA) for Steq...

Bio & Pharma SK Pharmteco bags obesity treatment deal worth up to $1.4 bn

SK Pharmteco Co., a contract development and manufacturing organization (CDMO), has secured an obesity treatment order worth up to 2 trillion won ($...

Bio & Pharma Celltrion gets approval of Omlyclo in Canada

South Korea’s Celltrion Inc., received new drug submission (NDS) approval from Health Canada for Omlyclo, the biosimilar of allergic asthma an...

Bio & Pharma Korea’s Lunit in AI-powered lung cancer diagnostics deal with AstraZeneca

Lunit Inc., a South Korean AI-powered cancer diagnostics company, has partnered with global biopharma giant AstraZeneca plc. to jointly enter the AI...

Bio & Pharma Celltrion releases Steqeyma in Europe

South Korea's Celltrion Inc. said on Monday it released Steqeyma (ustekinumab) in Europe, the biosimilar of autoimmune disease treatment Stelara.T...

Bio & Pharma PharmaResearch hosts 5th global symposium on 'Rejuran'

PharmaResearch Co. announced that it successfully held the 5th PharmaResearch Global Symposium (PGS) at the Lakai Sandpine Resort on Oct. ...

Energy DS Dansuk wins $750 mn SAF material order from Phillips 66

South Korea's DS Dansuk Co., which operates bioenergy, battery, and plastic recycling businesses, said on Monday it signed a 1 trillion won ($750 mi...

Bio & Pharma ViGenCell obtains approval for HLA-B5801 genetic diagnostic kit for adverse reactions to gout treatment

ViGenCell, a company specializing in immunotherapy, announced on Friday that it has obtained approval from the Ministry of Food and Drug Safety (MFD...

Bio & Pharma Celltrion's anti cancer drugs hold 90% market share in C.America

South Korea’s Celltrion Inc. said on Friday that its cancer treatments have captured a 90% market share in several Central American countries....

Bio & Pharma Osstem Implant to boost digital dentistry business

South Korea's Osstem Implant Co., the world’s fourth-largest dental implant maker, will enhance its software system of digital dentistry. ...

Bio & Pharma Celltrion to supply breast, stomach cancer treatment to Brazil

Celltrion Inc., South Korea’s largest biosimilar maker, announced on Friday that its breast and stomach cancer treatment "Herzuma" (active ing...

Bio & Pharma SK Group’s 3rd-generation daughter comes to the fore

Chey Yoon-chung, the eldest daughter of SK Group Chairman Chey Tae-won, unexpectedly made her debut during an SK Biopharmaceuticals Co. video confer...

Bio & Pharma CHA Healthcare incorporates Singapore's SMG as subsidiary

South Korea's CHA Healthcare Co., CHA Biotech's overseas medical business affiliate incorporated Singapore's SMG as a subsidiary. CHA Healthcare an...

Mergers & Acquisitions GS E&C in talks to sell entire stake in GS Elevator to Chinese firm

South Korea’s GS Engineering & Construction Corp. (GS E&C) is in talks to sell its entire stake in GS Elevator Co. to a Chinese strate...

Bio & Pharma Celltrion gets approval of Steqeyma in Canada

South Korea’s Celltrion Inc., received new drug submission (NDS) approval from Health Canada for Steqeyma, a biosimilar of the autoimmune dise...

Electronics Dreamtech builds electronics, medical device factory in India

South Korean electronics components maker Dreamtech said on Monday that it built a new factory in India's Greater Noida.The company invested 85.1 bi...

Artificial intelligence Spear Korea to acquire AI medical firm Life Semantics

South Korea's aerospace materials company Spear Korea will acquire artificial intelligence (AI) medical firm Life Semantics Co. Life Semantics ...

Bio & Pharma GC Biopharma sells HK subsidiary to CR Pharm Group for $254 mn

South Korea’s GC Biopharma Corp. announced on Wednesday that it signed a share purchase agreement (SPA) to sell all its shares in its Hong Kon...

Bio & Pharma Samsung Elec invests in US bio startup Element Biosciences

Samsung Electronics Co., the world’s top memory chipmaker, said on Friday it has invested in US biotech startup Element Biosciences Inc. to ex...

Bio & Pharma PharmaResearch acquires TuringBio for digital therapeutics

PharmaResearch Co., a South Korean company specializing in regenerative medicine, announced on Wednesday that it acquired TuringBio, an AI-based dig...